VirtualScopics, Inc. to Host Third Quarter 2014 Earnings Conference Call and Webcast Live on Thursday, November 13, 2014

ROCHESTER, NY / ACCESSWIRE / November 12, 2014 / VirtualScopics, Inc. VSCP will host a conference call and live webcast to discuss the results of the third quarter 2014, to be held Thursday, November 13, 2014 at 8:30 AM Eastern Time.

To participate in this event, dial 877-407-8035 domestically, or 201-689-8035 internationally, approximately 5 to 10 minutes before the beginning of the call. Additionally, you can listen to the event online at www.investorcalendar.com/IC/CEPage.asp?ID=173384 as well as via the VirtualScopics website (virtualscopics.investorroom.com/webcasts).

If you are unable to participate during the live webcast, the event archive will be available at www.investorcalendar.com/IC/CEPage.asp?ID=173384 or virtualscopics.investorroom.com/webcasts.

You may access the teleconference replay by dialing 877-660-6853 domestically or 201-612-7415 internationally, referencing conference ID #13594825. The replay will be available beginning approximately 2 hours after the completion of the live event, ending at midnight Eastern on December 13, 2014.

About VirtualScopics, Inc.

VirtualScopics, Inc. (VSCP) is a leading provider of clinical trial imaging solutions to accelerate drug and medical device development. For risk-averse, time-constrained Clinical Trial Study Teams, Medical Directors and Imaging Scientists who require quality imaging data delivered on-time, within budget and on a consistent basis, VirtualScopics' clinical trial imaging solutions are an inspired true exception to commonly accepted services provided by other clinical trial imaging providers. Because of the scientific and operational flexibility and responsiveness available, VirtualScopics' clinical trial imaging solutions deliver special performance advantages compared to other image service providers that offer common, every day clinical trial imaging services. For more information about VirtualScopics, Inc., please visit www.virtualscopics.com.

SOURCE: VirtualScopics, Inc.